Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Radiosurgery as primary management for Acromegaly.

Sims-Williams HP, Rajapaksa K, Sinha S, Radatz M, Walton L, Yianni J, Newell-Price J.

Clin Endocrinol (Oxf). 2018 Oct 4. doi: 10.1111/cen.13870. [Epub ahead of print]

PMID:
30288782
2.

Salivary cortisone to estimate cortisol exposure and sampling frequency required based on serum cortisol measurements.

Harrison RF, Debono M, Whitaker MJ, Keevil BG, Newell-Price J, Ross RJ.

J Clin Endocrinol Metab. 2018 Oct 3. doi: 10.1210/jc.2018-01172. [Epub ahead of print]

PMID:
30285244
3.

Correction to: Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives.

Altieri B, Muscogiuri G, Paschou SA, Vryonidou A, Della Casa S, Pontecorvi A, Fassnacht M, Ronchi CL, Newell-Price J.

Endocrine. 2018 Sep 10. doi: 10.1007/s12020-018-1728-8. [Epub ahead of print]

PMID:
30203121
4.

Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives.

Altieri B, Muscogiuri G, Paschou SA, Vryonidou A, Della Casa S, Pontecorvi A, Fassnacht M, Ronchi CL, Newell-Price J.

Endocrine. 2018 Aug 2. doi: 10.1007/s12020-018-1696-z. [Epub ahead of print] Review. Erratum in: Endocrine. 2018 Sep 10;:.

PMID:
30073456
5.

Advances in the medical treatment of Cushing's syndrome.

Feelders RA, Newell-Price J, Pivonello R, Nieman LK, Hofland LJ, Lacroix A.

Lancet Diabetes Endocrinol. 2018 Jul 19. pii: S2213-8587(18)30155-4. doi: 10.1016/S2213-8587(18)30155-4. [Epub ahead of print] Review.

PMID:
30033041
6.

A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly.

Trainer PJ, Newell-Price JDC, Ayuk J, Aylwin SJB, Rees A, Drake W, Chanson P, Brue T, Webb SM, Fajardo C, Aller J, McCormack AI, Torpy DJ, Tachas G, Atley L, Ryder D, Bidlingmaier M.

Eur J Endocrinol. 2018 Aug;179(2):97-108. doi: 10.1530/EJE-18-0138. Epub 2018 May 22.

7.

New Molecular Targets for Treatment of Cushing's Disease.

Foulkes E, Newell-Price J.

Endocrinol Metab Clin North Am. 2018 Jun;47(2):367-373. doi: 10.1016/j.ecl.2018.02.006. Review.

PMID:
29754637
8.

Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN.

Valassi E, Feelders R, Maiter D, Chanson P, Yaneva M, Reincke M, Krsek M, Tóth M, Webb SM, Santos A, Paiva I, Komerdus I, Droste M, Tabarin A, Strasburger CJ, Franz H, Trainer PJ, Newell-Price J, Wass JA, Papakokkinou E, Ragnarsson O; ERCUSYN Study Group.

Clin Endocrinol (Oxf). 2018 Jun;88(6):787-798. doi: 10.1111/cen.13600. Epub 2018 Apr 16. Erratum in: Clin Endocrinol (Oxf). 2018 Nov;89(5):678.

PMID:
29574994
9.

Development of a rapid liquid chromatography tandem mass spectrometry method for the quantitation of serum dexamethasone and its clinical verification.

Hawley JM, Owen LJ, Debono M, Newell-Price J, Keevil BG.

Ann Clin Biochem. 2018 Nov;55(6):665-672. doi: 10.1177/0004563218766566. Epub 2018 Mar 29.

PMID:
29534610
10.

Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN.

Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S, Webb SM, Yaneva M, Reincke M, Droste M, Komerdus I, Maiter D, Kastelan D, Chanson P, Pfeifer M, Strasburger CJ, Tóth M, Chabre O, Krsek M, Fajardo C, Bolanowski M, Santos A, Trainer PJ, Wass JAH, Tabarin A; ERCUSYN Study Group.

Eur J Endocrinol. 2018 Apr;178(4):399-409. doi: 10.1530/EJE-17-0997. Epub 2018 Feb 12.

PMID:
29440375
11.

Consider Addison's disease in differential diagnosis of eating disorders in children and young people.

Wass J, Newell-Price J, Arlt W.

BMJ. 2018 Jan 26;360:k277. doi: 10.1136/bmj.k277. No abstract available.

PMID:
29374011
12.

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016.

McCormack A, Dekkers OM, Petersenn S, Popovic V, Trouillas J, Raverot G, Burman P; ESE survey collaborators.

Eur J Endocrinol. 2018 Mar;178(3):265-276. doi: 10.1530/EJE-17-0933. Epub 2018 Jan 12.

PMID:
29330228
13.

A prospective longitudinal study of Pasireotide in Nelson's syndrome.

Daniel E, Debono M, Caunt S, Girio-Fragkoulakis C, Walters SJ, Akker SA, Grossman AB, Trainer PJ, Newell-Price J.

Pituitary. 2018 Jun;21(3):247-255. doi: 10.1007/s11102-017-0853-3.

14.

Assessing the potential impacts of a revised set of on-farm nutrient and sediment 'basic' control measures for reducing agricultural diffuse pollution across England.

Collins AL, Newell Price JP, Zhang Y, Gooday R, Naden PS, Skirvin D.

Sci Total Environ. 2018 Apr 15;621:1499-1511. doi: 10.1016/j.scitotenv.2017.10.078. Epub 2017 Oct 18.

15.

Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial.

Lacroix A, Gu F, Gallardo W, Pivonello R, Yu Y, Witek P, Boscaro M, Salvatori R, Yamada M, Tauchmanova L, Roughton M, Ravichandran S, Petersenn S, Biller BMK, Newell-Price J; Pasireotide G2304 Study Group.

Lancet Diabetes Endocrinol. 2018 Jan;6(1):17-26. doi: 10.1016/S2213-8587(17)30326-1. Epub 2017 Oct 12. Erratum in: Lancet Diabetes Endocrinol. 2018 Jan;6(1):e1.

PMID:
29032078
16.

Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion.

Debono M, Harrison RF, Chadarevian R, Gueroult C, Abitbol JL, Newell-Price J.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3461-3469. doi: 10.1210/jc.2017-00823.

17.

Pasireotide: successful treatment of a sparsely granulated tumour in a resistant case of acromegaly.

Amarawardena WKMG, Liyanarachchi KD, Newell-Price JDC, Ross RJM, Iacovazzo D, Debono M.

Endocrinol Diabetes Metab Case Rep. 2017 Jul 10;2017. pii: 17-0067. doi: 10.1530/EDM-17-0067. eCollection 2017.

18.

CME Endocrinology (108461): self-assessment questionnaire.

Newell-Price J, Chowdhury TA.

Clin Med (Lond). 2017 Jun;17(3):278-279. doi: 10.7861/clinmedicine.17-3-278. No abstract available.

PMID:
28572232
19.

Recent advances in understanding Cushing disease: resistance to glucocorticoid negative feedback and somatic USP8 mutations.

Daniel E, Newell-Price J.

F1000Res. 2017 May 2;6:613. doi: 10.12688/f1000research.10968.1. eCollection 2017. Review.

20.

Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN.

Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S, Webb SM, Yaneva M, Reincke M, Droste M, Komerdus I, Maiter D, Kastelan D, Chanson P, Pfeifer M, Strasburger CJ, Tóth M, Chabre O, Tabarin A, Krsek M, Fajardo C, Bolanowski M, Santos A, Wass JA, Trainer PJ; ERCUSYN Study Group.

Eur J Endocrinol. 2017 May;176(5):613-624. doi: 10.1530/EJE-16-0967.

PMID:
28377460

Supplemental Content

Loading ...
Support Center